Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer.

Kwan ML, Roh JM, Laurent CA, Lee J, Tang L, Hershman D, Kushi LH, Yao S.

Cancer Causes Control. 2017 Jun;28(6):557-562. doi: 10.1007/s10552-017-0888-9. Epub 2017 Mar 27.

PMID:
28349440
2.

Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.

Cespedes Feliciano EM, Kwan ML, Kushi LH, Chen WY, Weltzien EK, Castillo AL, Sweeney C, Bernard PS, Caan BJ.

Cancer. 2017 Jul 1;123(13):2535-2542. doi: 10.1002/cncr.30637. Epub 2017 Mar 13.

PMID:
28295245
3.

Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study.

Shariff-Marco S, Von Behren J, Reynolds P, Keegan TH, Hertz A, Kwan ML, Roh JM, Thomsen C, Kroenke CH, Ambrosone C, Kushi LH, Gomez SL.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):505-515. doi: 10.1158/1055-9965.EPI-16-0932. Epub 2017 Feb 2.

PMID:
28154107
4.

Cancer Data and Aboriginal Disparities (CanDAD)-developing an Advanced Cancer Data System for Aboriginal people in South Australia: a mixed methods research protocol.

Yerrell PH, Roder D, Cargo M, Reilly R, Banham D, Micklem JM, Morey K, Stewart HB, Stajic J, Norris M, Brown A; CanDAD Aboriginal Community Reference Group and CanDAD Investigators.

BMJ Open. 2016 Dec 23;6(12):e012505. doi: 10.1136/bmjopen-2016-012505.

5.

Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis.

Yao S, Zhang Y, Tang L, Roh JM, Laurent CA, Hong CC, Hahn T, Lo JC, Ambrosone CB, Kushi LH, Kwan ML.

Breast Cancer Res Treat. 2017 Feb;161(3):501-513. doi: 10.1007/s10549-016-4068-5. Epub 2016 Dec 3.

PMID:
27915435
6.

Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study.

Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng TD, Hong CC, McCann SE, Tang L, Davis W, Liu S, Quesenberry CP Jr, Lee MM, Ambrosone CB, Kushi LH.

JAMA Oncol. 2017 Mar 1;3(3):351-357. doi: 10.1001/jamaoncol.2016.4188.

PMID:
27832250
7.

Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies.

Jones LW, Kwan ML, Weltzien E, Chandarlapaty S, Sternfeld B, Sweeney C, Bernard PS, Castillo A, Habel LA, Kroenke CH, Langholz BM, Queensberry CP Jr, Dang C, Weigelt B, Kushi LH, Caan BJ.

Cancer Res. 2016 Sep 15;76(18):5415-22. doi: 10.1158/0008-5472.CAN-15-3307. Epub 2016 Aug 3.

PMID:
27488523
8.

Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study.

Kwan ML, Yao S, Lee VS, Roh JM, Zhu Q, Ergas IJ, Liu Q, Zhang Y, Kutner SE, Quesenberry CP Jr, Ambrosone CB, Kushi LH.

Breast Cancer Res Treat. 2016 Aug;159(1):119-29. doi: 10.1007/s10549-016-3913-x. Epub 2016 Jul 22.

PMID:
27449493
9.

The Alberta Moving Beyond Breast Cancer (AMBER) Cohort Study: Recruitment, Baseline Assessment, and Description of the First 500 Participants.

Courneya KS, McNeely ML, Culos-Reed SN, Vallance JK, Bell GJ, Mackey JR, Matthews CE, Morielli AR, Cook D, MacLaughlin S, Farris MS, Voaklander S, O'Reilly R, Friedenreich CM.

BMC Cancer. 2016 Jul 14;16:481. doi: 10.1186/s12885-016-2534-4.

10.

Breast cancer multigene testing trends and impact on chemotherapy use.

Ray GT, Mandelblatt J, Habel LA, Ramsey S, Kushi LH, Li Y, Lieu TA.

Am J Manag Care. 2016 May 1;22(5):e153-60.

11.

Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer.

Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, Kwan ML, Quesenberry CP Jr, Scott J, Sternfeld B, Yu A, Kushi LH, Caan BJ.

J Clin Oncol. 2016 Aug 10;34(23):2743-9. doi: 10.1200/JCO.2015.65.6603. Epub 2016 May 23.

PMID:
27217451
12.

Prevention and treatment of bone fragility in cancer patient.

Ottanelli S.

Clin Cases Miner Bone Metab. 2015 May-Aug;12(2):116-29. doi: 10.11138/ccmbm/2015.12.2.116. Epub 2015 Oct 26. Review.

13.

The impact of DNA input amount and DNA source on the performance of whole-exome sequencing in cancer epidemiology.

Zhu Q, Hu Q, Shepherd L, Wang J, Wei L, Morrison CD, Conroy JM, Glenn ST, Davis W, Kwan ML, Ergas IJ, Roh JM, Kushi LH, Ambrosone CB, Liu S, Yao S.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1207-13. doi: 10.1158/1055-9965.EPI-15-0205. Epub 2015 May 19.

14.

Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival.

Kwan ML, Bernard PS, Kroenke CH, Factor RE, Habel LA, Weltzien EK, Castillo A, Gunderson EP, Maxfield KS, Stijleman IJ, Langholz BM, Quesenberry CP Jr, Kushi LH, Sweeney C, Caan BJ.

J Natl Cancer Inst. 2015 Apr 28;107(7). pii: djv087. doi: 10.1093/jnci/djv087. Print 2015 Jul.

15.

Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression.

Kwan ML, Kroenke CH, Sweeney C, Bernard PS, Weltzien EK, Castillo A, Factor RE, Maxfield KS, Stijleman IJ, Kushi LH, Quesenberry CP Jr, Habel LA, Caan BJ.

BMC Cancer. 2015 Apr 14;15:278. doi: 10.1186/s12885-015-1263-4.

16.

Bone health history in breast cancer patients on aromatase inhibitors.

Kwan ML, Lo JC, Tang L, Laurent CA, Roh JM, Chandra M, Hahn TE, Hong CC, Sucheston-Campbell L, Hershman DL, Quesenberry CP Jr, Ambrosone CB, Kushi LH, Yao S.

PLoS One. 2014 Oct 29;9(10):e111477. doi: 10.1371/journal.pone.0111477. eCollection 2014.

17.

Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data.

Mandelblatt JS, Huang K, Makgoeng SB, Luta G, Song JX, Tallarico M, Roh JM, Munneke JR, Houlston CA, McGuckin ME, Cai L, Clarke Hillyer G, Hershman DL, Neugut AI, Isaacs C, Kushi L.

J Oncol Pract. 2015 Jan;11(1):e1-8. doi: 10.1200/JOP.2013.001288. Epub 2014 Aug 26.

18.

Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study.

Greenlee H, Kwan ML, Ergas IJ, Strizich G, Roh JM, Wilson AT, Lee M, Sherman KJ, Ambrosone CB, Hershman DL, Neugut AI, Kushi LH.

BMC Cancer. 2014 May 29;14:382. doi: 10.1186/1471-2407-14-382.

19.

Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression.

Kroenke CH, Sweeney C, Kwan ML, Quesenberry CP, Weltzien EK, Habel LA, Castillo A, Bernard PS, Factor RE, Kushi LH, Caan BJ.

Breast Cancer Res Treat. 2014 Apr;144(3):689-99. doi: 10.1007/s10549-014-2899-5. Epub 2014 Mar 7.

20.

Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes.

Caan BJ, Sweeney C, Habel LA, Kwan ML, Kroenke CH, Weltzien EK, Quesenberry CP Jr, Castillo A, Factor RE, Kushi LH, Bernard PS.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):725-34. doi: 10.1158/1055-9965.EPI-13-1017. Epub 2014 Feb 12.

Supplemental Content

Support Center